Treatment
Stride clinical trials
We’re tracking 13 recruiting studies that include Stride, each written for real people, not researchers, below.
Recruiting studies
- NCT06880523RecruitingPhase 2
Adding lenvatinib to immunotherapy for liver cancer
This trial tests adding lenvatinib (a targeted therapy pill) to a combination of two immunotherapy drugs (durvalumab and tremelimumab) for people with liver cancer that cannot be removed by surgery. The goal is to see if the three-drug approach works better than the two immunotherapy drugs alone.
Calgary, AlbertaAges 18 years+ - NCT07092176Recruiting
Steady Stride fall prevention study for older adults
This study compares a new fall-prevention program, Steady Stride, to the usual care for older adults who have fallen recently. It aims to help you stay steady and avoid future falls so you can keep living independently.
Baltimore, MarylandAges 65 years+ - NCT06662292Recruiting
Team exercise study with smartphone support
This study will help you and your team get more active using a smartphone program and a wearable activity tracker. You'll work together to increase your daily steps and physical activity.
Columbia, South CarolinaAges 18 years+ - NCT07168941Recruiting
New approach to improve mobility for people with disabilities
This study is testing a new approach to help people with disabilities improve their mobility and daily functioning. It may be a good fit if you live in the US, speak English, and are in good mental health.
East Hanover, New JerseyAges 18–65 - NCT07612878Recruiting
Registry tracking COPD patients starting dupilumab treatment
This is a registry—an observational study tracking patients with COPD (chronic lung disease) who are newly starting a medication called dupilumab. Researchers will follow your health outcomes to learn how well this treatment works in real-world practice.
Indianapolis, IndianaAges 40 years+ - NCT07607769Recruiting
Tremelimumab and Durvalumab for Untreated Advanced Liver Cancer
This Italian study follows patients with advanced liver cancer (hepatocellular carcinoma) who receive a combination immunotherapy treatment called STRIDE for the first time. The trial tracks how well the treatment works, how it affects quality of life, and its safety in people with moderate to severe liver disease.
AnconaAges 18–100 - NCT06747117Recruiting
Removing blood clots in leg arteries with the Indigo system
This study tests a device that vacuums out blood clots from blocked leg arteries, potentially restoring blood flow without open surgery.
Scottsdale, ArizonaAges 18 years+ - NCT07489976RecruitingPhase 2
Study of durvalumab for advanced liver cancer not treatable by surgery
This trial tests the drug durvalumab in people with advanced liver cancer (HCC) that has spread beyond the liver and cannot be removed by surgery. It aims to see if durvalumab can help shrink tumors or slow the disease.
Los Angeles, CaliforniaAges 18 years+ - NCT07175441RecruitingPhase 2
Testing a new drug combo for advanced liver cancer
This trial tests a new drug called RBS2418 added to two immunotherapy medicines (tremelimumab and durvalumab) for people with advanced liver cancer that cannot be removed by surgery. The goal is to see if the combination helps patients who are starting their first treatment for this stage of liver cancer.
Baltimore, MarylandAges 18 years+ - NCT06255925Recruiting
A strength-based job support program for autistic people
This trial tests a program that helps people on the autism spectrum find and keep jobs by building on their strengths. It is designed for younger people (ages 14–26) who live in the U.S. and can communicate in English.
East Hanover, New JerseyAges 14–26 - NCT06315179Recruiting
Spatial gene study for inflammatory bowel disease
This study looks at tissue samples from people with suspected Crohn's disease, ulcerative colitis, or indeterminate colitis. The goal is to understand these conditions better and may lead to improved treatments.
Seattle, WashingtonAges 6–21 - NCT06380569Recruiting
A strength-based program for job interview skills (ages 14-26)
This study tests a program that helps young adults build on their strengths to improve job interview skills in community settings. It aims to see if focusing on what you're good at can boost confidence and performance in interviews.
East Hanover, New JerseyAges 14–26 - NCT07237386Recruiting
Testing a smart insole for walking in people with brain or spinal cord injury
This study tests a special insole that measures how you walk, compared with a high-tech walking lab. It's for people with stroke, spinal cord injury, or brain injury who can walk on their own for 6 minutes.
GhentAges Any age
What Stride is being studied for
Conditions with recruiting Stride studies.
Common questions
- Are there clinical trials studying Stride?
- Yes. Clin2 currently lists 13 recruiting studies that include Stride, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a Stride trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is Stride an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether Stride or a specific trial is right for you.
Related treatments
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.